What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Explore various ways to earn cash before payday to help you manage your finances. Find quick solutions that can provide immediate relief.
22,513 articlesWhen a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Investors are watching nextnav (nn) 2025 earnings to see if the company can turn its positioning tech into steady pro...
A growing share of homeowners won’t sell price—and that stance is reshaping markets. This article explains how small ...
Lucid Group sparked a sharp rally after the CEO denied bankruptcy rumors and take-private chatter. This article break...
Cruise investors wrestle with Carnival earnings anxiety: good, the push-pull between sunny passenger demand and risin...
Investors are buzzing about SpaceX and a potential IPO that could push the company toward a $2 trillion valuation. Th...
In 2026, investors face a choice between rapid disruption and steady government contracts. This article compares Spac...
Tesla fans and skeptics alike have watched the stock struggle even as leadership paints an upbeat picture. This artic...
A patient fund boosted its stake by roughly $7 million in a major packaging company even though the stock trailed the...
A sky‑high dividend can be tempting, but it often signals trouble. This guide explains how to tell whether this ultim...
Want anchors in a stormy market? Meet three dividend stocks never sell. These blue-chip picks blend reliable cash flo...
Investors rotated into AI infrastructure plays this week, lifting Argan and similar names. This piece breaks down the...